1. Home
  2. ACET vs LGO Comparison

ACET vs LGO Comparison

Compare ACET & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$2.48

Market Cap

28.0M

Sector

Health Care

ML Signal

N/A

Logo Largo Inc.

LGO

Largo Inc.

N/A

Current Price

$0.20

Market Cap

23.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
LGO
Founded
1947
1988
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.0M
23.6M
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
ACET
LGO
Price
$2.48
$0.20
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
★ $29.00
$0.95
AVG Volume (30 Days)
284.0K
★ 711.0K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.90
Revenue Next Year
N/A
$23.10
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.20
52 Week High
$9.97
$1.93

Technical Indicators

Market Signals
Indicator
ACET
LGO
Relative Strength Index (RSI) 15.77 16.15
Support Level N/A N/A
Resistance Level $9.51 $0.37
Average True Range (ATR) 0.26 0.03
MACD 0.08 -0.01
Stochastic Oscillator 6.57 0.65

Price Performance

Historical Comparison
ACET
LGO

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: